Results
14
Companies which are more than 50% undervalued based on analyst price target.
14 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
ASTS | US$23.29 | -1.3% | 363.9% | US$6.8b | US$35.94 | PS1866.4x | E78.5% | n/a | ||
LBTY.A | US$13.99 | 5.4% | -12.8% | US$5.0b | US$22.88 | PS0.7x | E53.3% | 71.9% | ||
GSAT | US$1.90 | 11.1% | 19.5% | US$3.4b | US$3.33 | PS14.9x | E75.6% | n/a | ||
VEON | US$32.15 | 3.9% | 62.6% | US$2.3b | US$56.50 | PE7.4x | S7.7% | 0% | ||
LILA | US$7.06 | -0.1% | 1.1% | US$1.4b | US$11.10 | PS0.3x | E117.8% | n/a | ||
IHS | US$3.26 | 16.8% | -34.1% | US$1.0b | US$7.25 | PS0.6x | E101.1% | n/a | ||
GOGO | US$8.14 | 5.2% | -19.1% | US$1.0b | US$12.75 | PE18.1x | E19.3% | n/a | ||
SHEN | US$13.15 | 5.5% | -41.2% | US$705.5m | US$26.00 | PS2.2x | E-72.3% | 0.7% | ||
ATEX | US$34.81 | 5.2% | 9.3% | US$613.7m | US$78.67 | PS115.6x | E22.9% | n/a | ||
ATNI | US$20.18 | 0.9% | -32.6% | US$292.7m | US$32.67 | PS0.4x | E100.4% | 4.8% | ||
SIFY | US$3.45 | 16.6% | -61.7% | US$108.5m | US$18.00 | PE64.5x | E144.2% | 0% | ||
UCL | US$1.20 | -6.3% | -47.4% | US$43.9m | US$9.50 | PE10.6x | S26.0% | n/a | ||
SURG | US$1.92 | 31.5% | -71.1% | US$41.9m | US$6.00 | PS0.5x | E110.5% | n/a | ||
KORE | US$1.70 | -10.5% | -37.6% | US$29.7m | US$5.13 | PS0.1x | E68.2% | n/a |